other well-resourced countries. To better understand the causes, patterns, risk factors, and outcomes related to PPH, medical claims data have been used for large-scale evaluations of PPH epidemiology. 1, [3] [4] [5] However, there has been limited examination of the accuracy of claims data generated from International Classification of Diseases (ICD) codes for PPH. Determining the accuracy of these codes is vital for reaching valid conclusions about the epidemiology of PPH and the use of key interventions for PPH management, including transfusion therapy. Since October 2015, hospitals in the United States have transitioned to using ICD 10th Revision (ICD-10) diagnostic and procedure codes for hospital billing. 6 Since this transition is recent and US population-wide studies of PPH using ICD-10 codes are scarce, studies examining large administrative data sets must still rely on ICD Ninth Revision (ICD-9) diagnostic codes. However, to our knowledge, the accuracy of ICD-9 codes for PPH are poorly described. This is particularly surprising considering that national estimates of PPH burden and outcomes have relied on administrative data. 1, [3] [4] [5] Furthermore, these data are also used to inform obstetric agencies, such as the National Partnership for Maternal Safety, who publish safety bundles for PPH prevention and management. 7 Estimated blood loss (EBL) is central to the diagnosis of PPH. 8, 9 International obstetric societies have provided EBL thresholds for classifying PPH. 8, 10 The most commonly used definition is an EBL of more than 500 mL after vaginal delivery or an EBL of more than 1000 mL after Cesarean delivery. 8 Of note, in the most recent PPH Practice Bulletin published by the American College of Obstetricians and Gynecologists in 2017, 9 PPH is defined as a cumulative blood loss of at least 1000 mL or blood loss accompanied by signs of symptoms of hypovolemia within 24 hours of birth. Given that clinicians are most familiar with defining PPH using EBL thresholds and routinely document EBL volume at delivery into patients' medical records, and that EBL data can now be retrieved electronically, linking a clinical database containing EBL data with a discharge database containing ICD-9 codes provides an ideal opportunity to examine the accuracy of ICD-9 codes for PPH. We sought to evaluate the performance characteristics of ICD-9 diagnostic codes for PPH within an administrative discharge database by comparison to the recorded EBL from electronic medical records in a large sample of women who underwent Cesarean delivery. For this study, we used data from Kaiser Permanente Northern California (KPNC), an integrated health care delivery system in the United States. 10, [16] [17] [18] we defined PPH as an EBL of at least 1000 mL and severe PPH as an EBL of at least 1500 mL. We excluded women with missing EBL data. Because of concern about the accuracy of very low EBL values, we also excluded women with an EBL of less than 100 mL. Information on PPH ICD-9 codes was obtained directly from KPNC VDW data sets. The following ICD-9 codes for PPH were identified: 666.0x (PPH from retained placenta), 666.1x (PPH from uterine atony), and 666.2x (delayed or secondary PPH); the "x" indicates all codes for 666.0, 666.1, and 666.2 down to the level of the fifth digit subclassification. Coders typically review medical records in the maternal discharge record then apply relevant ICD-9 codes.
MATERIALS AND METHODS
We abstracted data on a number of demographic, medical, obstetric, and peripartum covariates. These characteristics were purposefully selected because they have been linked with PPH in prior studies. 4 Table S1 , available as supporting information in the online version of this paper) and were obtained from a linked KPNC maternal discharge database.
Statistical analyses
Using an EBL of at least 1000 mL as the "reference standard," we examined the performance characteristics of ICD-9 codes for PPH. We calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), with exact binomial 95% confidence intervals (CIs) for all women in the study cohort. We stratified results according to individual demographic, medical, obstetric, and peripartum characteristics. In a secondary analysis, we compared the performance characteristics of ICD-9 codes against a recorded EBL of at least 1500 mL (severe PPH). Finally, we performed an exploratory analysis to examine the influence of selected maternal characteristics on the correct PPH assignment using our EBL reference standard. We initially performed univariable logistic regression analysis to examine the associations between each variable and correct assignment of an ICD-9 PPH code. Factors with a p value of less than 0.1 on univariable analyses were then included into a multivariable regression model. All analyses were performed using computer software (Stata 12.0, Stata Corp.).
RESULTS
Our initial study cohort comprised 38,086 women who underwent Cesarean delivery at a KPNC obstetric center between 2010 and 2013. After excluding women with missing EBL data (n 5 2217) and women with EBL values less than 100 mL (n 5 345), our final analytic sample comprised 35,614 women. Characteristics of women in the final analytic sample as well as those with an ICD-9 code for PPH are presented in Table 1 . A total of 3194 (9%) women had any ICD-9 code for PPH; of these, 86 (0.2%) women had an ICD-9 code for PPH from retained placenta, 3032 (8.5%) had an ICD-9 code for PPH from uterine atony, and 104 (0.3%) had an ICD-9 code for delayed or secondary PPH. Based on available EBL data, the mean (95% CI) EBL among all women was 800 mL (250-1490 mL). Based on our a priori EBL thresholds for PPH and severe PPH, 8557 (24%) women experienced an EBL of at least 1000 mL and 1771 (5%) women experienced an EBL of at least 1500 mL. The prevalence of an ICD-9 code for transfusion was 3.1%.
For all women in the analytic sample, performance characteristics for any ICD-9 code for PPH were sensitivity 27.8%, specificity 97%, PPV 74.5%, and NPV 80.9%. Table 2 presents the performance characteristics according to each maternal characteristic. In our stratified analyses, the specificity, PPV, and NPV values remained fairly consistent across all maternal characteristics. Sensitivities remained low for the majority of the characteristics, except for coagulopathy (62.6%) and hysterectomy (85.2%). In the secondary analysis, the performance characteristics of the PPH ICD-9 codes were compared against an EBL of at least 1500 mL (Table S2 , available as supporting information in the online version of this paper). The specificity (93.8%) and NPV (97.9%) remained high, with an improvement in the sensitivity (61.7%). However, there was a moderate decrease in PPV to 34.2%. These indices remained fairly consistent across all maternal characteristics.
Findings from our univariable and multivariable analysis examining characteristics associated with correct assignment of PPH codes are presented in Table 3 . In the multivariable analysis, women who delivered at less than 37 weeks' gestational age were more likely to be coded correctly (adjusted odds ratio [aOR] 5 1.25; 95% CI 5 1.14-1.36) than those delivering between 37 and 41 weeks. Characteristics of women who were less likely to be correctly assigned a PPH code included maternal age of at least 35 years, black race, obesity, chronic anemia, gestational age at delivery of more than 41 weeks, multiple gestations, placenta previa, preeclampsia, induction of labor, labor, prolonged labor, chorioamnionitis, polyhydramnios, antepartum hemorrhage, and uterine rupture.
DISCUSSION
Administrative data sets containing ICD-9 codes are vital data sources for US population-wide studies of PPH. However, the accuracy of these codes has been poorly examined. In this validation study of ICD-9 codes for PPH within a population of women undergoing Cesarean delivery, the sensitivity was poor (28%), but the specificity and NPV were high (97 and 81%, respectively), and the PPV was moderately high (75%). These findings suggest that ICD-9 codes may underestimate the prevalence of PPH among women undergoing Cesarean delivery.
Few studies have assessed the accuracy of ICD-9 codes for PPH. Lydon-Rochelle and colleagues 23 compared hospital discharge data with information documented in the medical records of 4541 women who underwent delivery hospitalization in Washington State in 2000. Although the reported PPV (71.9%) for ICD-9 codes for PPH was similar to that observed in our study, there was a lower prevalence of PPH (4.7%). In a separate study of 1611 deliveries in 52 hospitals in California between 1992 and 1993 linking hospital records with hospital discharge data, the sensitivity (21%) was similar to our study but the PPV was substantially higher (98%). 24 In a systematic review of validation studies of maternal data in hospital discharge data sets, Lain and coworkers 25 pooled data to report the PPV, specificity, and sensitivity of specific obstetric complications, including PPH. Compared to our findings, PPV values were higher (ranging from 83.9% to 98%) and the specificity values were similar (ranging from 98.2% to 99.8%). Comparisons of sensitivity are more difficult because a wide range of reported sensitivity values was reported (21%-90.2%) in the review. None of these studies described the reference standard for defining PPH or reported performance characteristics of ICD-9 codes using EBL values as reference standards. This may account for some of the variability in the performance characteristics of PPH ICD-9 codes across these studies. In our study, using an EBL threshold of 1000 mL to define PPH, the sensitivity of ICD-9 codes for PPH was low (27.8%). The sensitivity only improved moderately (62%) using a threshold of 1500 mL. There are several possible explanations for these findings. First, obstetric diagnoses tend to be less accurately reported than obstetric procedures, such as mode of delivery. 25 Second, documentation of PPH in medical records may not depend on EBL or specific EBL thresholds. Third, it is possible that some patients may have experienced PPH in the postoperative period. Because EBL is typically recorded at the end of surgery, some late PPH events with codes for PPH would not have been identified using EBL data. Finally, for patients with hemorrhage-related morbidities, PPH episodes may be more accurately documented and coded. Our findings support this assertion in that we observed higher sensitivity and PPV values among women with coagulopathy (63 and 88%, respectively) and hysterectomy (85 and 93%, respectively).
In our regression analysis, we identified a number of maternal and obstetric characteristics (such as maternal age 35 years, black race, obesity, chronic anemia) that were associated with a reduced likelihood of correct assignment of PPH codes. As no clear patterns can be elucidated, it is unclear if these associations are spurious or chance findings. Further studies are needed to validate these findings and to investigate whether other unaccounted for factors influence coding accuracy, such as coder training and experience and facility quality control efforts.
Our main findings suggest that ICD-9 codes for PPH may substantially underestimate the disease burden of PPH. The low sensitivity of ICD-9 codes for PPH indicates that there is a need to improve current coding practices for PPH. As clinicians are prone to underestimating blood loss, especially when large volumes of blood are lost, 26, 27 these sensitivities may be overestimated. With the majority of nonfederal acute care US hospitals (83% in 2015) implementing electronic health records (EHRs), 28 a new source of health care data for epidemiologic studies is becoming available. Data recorded in EHR systems provide an opportunity to improve medical documentation of PPH, which may secondarily improve the accuracy of PPH coding. Alert systems could be developed to prompt clinicians to enter a diagnosis of PPH into the EHR based on prespecified criteria, especially for women at risk for PPH. To account for potential EBL underestimation, the presence of other morbidities strongly associated with severe PPH, such as severe postpartum anemia 11 and transfusion, 29 could be also be built into alert systems for enhancing PPH documentation in medical records. Alert systems would need to be carefully designed to limit the lack of physician response due to alert fatigue.
The main strengths of our analysis are the large study population and the ability to compare EBL data with ICD-9 codes for PPH by linkage of KPNC clinical and hospital discharge databases. We acknowledge that our study has several limitations. Because KPNC hospitals are located in Northern California, we are uncertain how generalizable our findings are to other US obstetric centers, especially if there are notable differences in coding practices for PPH. We cannot ascertain whether obstetricians or coders use EBL values or other clinical indices as the reference standard. Further studies are needed to determine what information in the medical records is used to code for PPH. Although blood loss cutoffs are somewhat arbitrary, the use of a blood loss cutoff of 1000 mL is supported by The Women's Health Registry Alliance (an initiative that comprises members from over 80 stakeholder obstetric and maternal health organizations in the United States), 30 the Brighton Collaboration Primary Postpartum Haemorrhage Working Group (a panel of experts formed to develop definition and guidelines for data collection and analysis for PPH), 31 and in the latest PPH guidelines from the American College of Obstetricians and Gynecologists. 9 We applied our EBL threshold using definitions for PPH that were current for our study period (2010-2013). 10 We acknowledge that the latest American College of Obstetricians and Gynecologists PPH definition is either blood loss accompanied by clinical features of hypovolemia or a cumulative blood loss of at least 1000 mL. 9 This new definition may further complicate how future cases of PPH are coded. Plus, due to a lack of international consensus for defining PPH, 10,32 variation in ICD-9 coding accuracy may exist in other developed countries. We classified ICD-9 codes 666.3x as coagulopathy and did not use these codes to identify women with PPH. Although misclassification is a potential concern, our estimates of coding accuracy are unlikely to be biased because, among 8557 women with an EBL of at least 1000 mL, only 52 (0.8%) women had a 666.3x ICD-9 code without an accompanying PPH code (666.0x, 666.1x, or 666.2x). The classification systems used by medical coders to identify episodes of PPH may be highly specific or complicated, resulting in inconsistencies in how PPH is coded. Similarly, we did not assess coding accuracy for other diagnoses and procedures identified using ICD-9 codes. As standardization of coding practices is lacking, improvements are needed to enhance the value of administrative databases for epidemiologic studies of PPH. Because hospitals transitioned to ICD-10 coding in October 2015, 6 the longterm impact of our findings is uncertain. Given that this transition is very recent, epidemiologic studies assessing temporal trends in PPH incidence will likely rely on identifying PPH events using both ICD-9 and ICD-10 codes. Moreover, coding inaccuracies may persist or even increase because the number of ICD-10 diagnostic codes (69,823) is far greater than that of ICD-9 diagnostic codes (14, 025) .
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In conclusion, our findings indicate that ICD-9 codes for PPH may underestimate the true prevalence of PPH using an EBL threshold of at least 1000 mL as a reference standard. These findings may serve as a useful benchmark 
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